Cover Image

Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies

Discontinuation of treatment with monoclonal antibodies (mAb) targeting the Calcitonin Gene-Related Peptide (CGRP) pathway leads to an increase in migraine frequency. We aimed to assess changes in free and total CGRP plasma concentrations after the discontinuation of CGRP(-receptor) mAbs. This prosp...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bianca Raffaelli (Author), Maria Terhart (Author), Mira Pauline Fitzek (Author), Kristin Sophie Lange (Author), Jasper Mecklenburg (Author), Lucas Hendrik Overeem (Author), Anke Siebert (Author), Elisabeth Storch (Author), Uwe Reuter (Author)
Format:	Book
Published:	MDPI AG, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response
by: Ja Bin Hong, et al.
Published: (2023)

Monoclonal antibodies blocking CGRP for prevention of migraine
by: Alicja Maziarczyk, et al.
Published: (2023)

Patients' and Health Care Workers' Perception of Migraine Images on the Internet: Cross-sectional Survey Study
by: Bianca Raffaelli, et al.
Published: (2021)

Anti-CGRP monoclonal antibodies in the treatment of migraine in women: impact on menstrual relared migraine and algodysmenorrhea
by: Anna V. Berdnikova, et al.
Published: (2023)

Effect of Xiongmatang Extract on Behavioral and TRPV1-CGRP/CGRP-R Pathway in Rats With Migraine
by: Dingding Liu, et al.
Published: (2022)

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies
by: Damiana Scuteri, et al.
Published: (2019)

Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo
by: Aqfan Jamaluddin, et al.
Published: (2022)

Calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraines in adults
by: Eric R Ocheretyaner, et al.
Published: (2022)

Calcitonin Gene-Related Peptide (CGRP)-Targeted Treatments-New Therapeutic Technologies for Migraine
by: Linda Sangalli, et al.
Published: (2023)

The PLGA nanoparticles for sustainable release of CGRP to ameliorate the inflammatory and vascular disorders in the lung of CGRP-deficient rats
by: Fang Wang, et al.
Published: (2021)

Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study
by: Calogera Butera, et al.
Published: (2024)

Small-molecule CGRP receptor antagonists: A new approach to the acute and preventive treatment of migraine
by: David Moreno-Ajona, et al.
Published: (2020)

Effectiveness of Switching CGRP Monoclonal Antibodies in Non-Responder Patients in the UAE: A Retrospective Study
by: Reem Suliman, et al.
Published: (2024)

Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations
by: Andrea Burgalassi, et al.
Published: (2024)

Pharmacokinetics, Pharmacodynamics and Drug-Drug Interactions of New Anti-Migraine Drugs-Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies
by: Danuta Szkutnik-Fiedler
Published: (2020)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
by: Casper Emil Christensen, et al.
Published: (2022)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers
by: David Monteith, et al.
Published: (2017)

Antagonism of CGRP Signaling by Rimegepant at Two Receptors
by: Kylie S. Pan, et al.
Published: (2020)

CGRP Is Critical for Hot Flushes in Ovariectomized Mice
by: Daniel B. Wilhelms, et al.
Published: (2019)

Effects of Anti-CGRP Monoclonal Antibodies on Neurophysiological and Clinical Outcomes: A Combined Transcranial Magnetic Stimulation and Algometer Study
by: Paolo Manganotti, et al.
Published: (2024)

Constipation as a possible predictor of poor treatment response in chronic migraine: A retrospective study of anti-calcitonin gene-related peptide (anti-CGRP) monoclonal antibodies and the impact of switching
by: Sena Uzun, et al.
Published: (2024)

Blocking the CGRP Receptor: Differences across Human Vascular Beds
by: Tessa de Vries, et al.
Published: (2023)

Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence-What Do We Know So Far?
by: Theodoros Mavridis, et al.
Published: (2021)

Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats
by: Ji Guangchen, et al.
Published: (2010)

Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety
by: M. T. Corasaniti, et al.
Published: (2023)

Gel-forming antagonist provides a lasting effect on CGRP-induced vasodilation
by: Chia Lin Chang, et al.
Published: (2022)

Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
by: Nina Sonne, et al.
Published: (2021)

Pain-related synaptic plasticity in spinal dorsal horn neurons: role of CGRP
by: Willis William D, et al.
Published: (2006)

Determining the Evolution of Headache Among Regular Users of a Daily Electronic Diary via a Smartphone App: Observational Study
by: Bianca Raffaelli, et al.
Published: (2021)

Effect of intracanal diode laser application and low-level laser therapy on CGRP change
by: Hakan Arslan, et al.
Published: (2019)

Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons
by: Lavinia Boccia, et al.
Published: (2022)

Serum CGRP Changes following Ultrasound-Guided Bilateral Greater-Occipital-Nerve Block
by: Abdelrahman Abbas, et al.
Published: (2022)

The impact of topiramate, botulinum toxin type A, and CGRP-antibodies on medication overuse headache in patients with chronic migraine: A protocol for systematic review and meta-analysis
by: Samita Giri, et al.
Published: (2022)

CGRP neuropeptide levels in patients with endometriosis-related pain treated with dienogest: a comparative study
by: Shahla Chaichian, et al.
Published: (2024)

Involvement of CGRP receptor RAMP1 in cluster headache: A Swedish case-control study
by: Julia M Michalska, et al.
Published: (2019)

Efficient and Scalable Enantioselective Synthesis of a Key Intermediate for Rimegepant: An Oral CGRP Receptor Antagonist
by: Zhonghua Luo, et al.
Published: (2024)

Semi-Automated Recording of Facial Sensitivity in Rat Demonstrates Antinociceptive Effects of the Anti-CGRP Antibody Fremanezumab
by: Nicola Benedicter, et al.
Published: (2023)

On the possible role of ERK, p38 and CaMKII in the regulation of CGRP expression in morphine-tolerant rats
by: Quirion Remi, et al.
Published: (2011)

The effect of capsaicin on expression patterns of CGRP in trigeminal ganglion and trigeminal nucleus caudalis following experimental tooth movement in rats
by: Yang ZHOU, et al.

Investigating the effect of cGRP78 vaccine against different cancer cells and its role in reducing melanoma metastasis
by: Hamed Zare, et al.
Published: (2024)